BRCA1 and neoplasm: Furthermore, the expression of molecules such as CD8, CD3, FOXP3, PD1, CTLA4, and GZMB is significantly increased in BRCA1 mutated tumor samples, signifying a robust T cell response in BRCA1 mutant TNBCs but a more prominent T cell exhaustion [42].